In a recent exploratory analysis of patients with stage III CRC treated with 5-fluorouracil and leucovorin alone (FL) or irinotecan (IFL), CIMP-positive patients treated with IFL showed a trend towards increased OS compared with those treated with FL ( Shiovitz et al , 2014 ).
← all excerpts
Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.
1
—
—